Fundz

Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc.

PUBLIC · ACADSep 23, 2024

Position

Chief Executive Officer

Company

Acadia Pharmaceuticals

Catherine Owen Adams
San DiegoBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as the new Chief Executive Officer (CEO), succeeding Steve Davis. Catherine Owen Adams brings extensive pharmaceutical industry experience to her new role, with proven leadership in driving growth and innovation.

Quick answer

Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc. (September 23, 2024). Acadia Pharmaceuticals is based in San Diego, California, United States.

Who is the new Chief Executive Officer at Acadia Pharmaceuticals?
Acadia Pharmaceuticals named Catherine Owen Adams Chief Executive Officer, announced September 23, 2024.
What did Acadia Pharmaceuticals announce on September 23, 2024?
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as the new Chief Executive Officer (CEO), succeeding Steve Davis. Catherine Owen Adams brings extensive pharmaceutical industry experience to her new role, with proven leadership in driving growth and innovation.
What does Acadia Pharmaceuticals do?
Acadia is advancing breakthroughs in neuroscience to elevate life.
Where is Acadia Pharmaceuticals based?
Acadia Pharmaceuticals is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
89bio (September 17, 2024), Pfizer (September 5, 2024), Forward Therapeutics (September 3, 2024) and Belite Bio (September 1, 2024) also announced leadership changes within 45 days of Acadia Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Acadia Pharmaceuticals, and when

A new leader at Acadia Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Acadia Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acadia Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acadia Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acadia Pharmaceuticals

Location

12830 El Camino Real

San Diego, California, United States

About

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acadia Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Acadia Pharmaceuticals's next move

Learn about Strategic plan

Acadia Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.